FDA advisory panel recommends loosening restrictions on 2 unapproved peptides
Summary
An FDA advisory panel suggested loosening rules on the use of two peptides that are currently not approved. Peptides are small chains of amino acids that affect different body functions.Key Facts
- The FDA panel recommended easing restrictions on two specific peptides.
- These peptides are not yet approved by the FDA.
- Peptides are made of short chains of amino acids.
- They help control various processes in the body.
- The recommendation came during a panel meeting on Thursday.
- The panel’s suggestion could influence future FDA decisions.
- The news was reported by CBS News correspondent Adam Yamaguchi.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
